Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 13;31(40):4398-405.
doi: 10.1016/j.vaccine.2013.07.003. Epub 2013 Jul 13.

Behavioral risk assessment in HIV Vaccine Trials Network (HVTN) clinical trials: a qualitative study exploring HVTN staff perspectives

Michele Peake Andrasik  1 , Shelly T Karuna, Michelle Nebergall, Beryl A Koblin, Jim G Kublin; NIAID HIV Vaccine Trials Network
Affiliations

Behavioral risk assessment in HIV Vaccine Trials Network (HVTN) clinical trials: a qualitative study exploring HVTN staff perspectives

Michele Peake Andrasik et al. Vaccine. .

Abstract

In HIV vaccine trials, the collection and analysis of participant behavior data associated with risk of acquiring HIV-infection is important for a number of reasons. Although the rationale for behavioral risk assessment in HIV vaccine clinical trials is clear, consistent collection of behavioral data over time and across protocols has been challenging for the HIV Vaccine Trials Network (HVTN). Integrating biomedical and behavioral research within the same preventive vaccine clinical trial has proven difficult. The HVTN conducted an internal landscape analysis to: (1) evaluate the challenges of behavioral risk assessment in HIV vaccine trials and observational studies; (2) explore the impact of the Step Study on behavioral risk assessment measures; and (3) identify strategies to overcome existing challenges and improve the quality of data resulting from behavioral risk analysis. These analyses of behavioral risk within the HVTN revealed several challenges and recommendations for improved behavioral risk data collection in future protocols. The recommendations for improvement include: (1) establishment of protocol-specific behavioral risk working groups that include social and behavioral experts; (2) provision of behavioral rationale and objectives to the development team; (3) creation of a template for geographic- and population-specific assessment of low and high risk behaviors; and (4) pilot testing of behavioral risk assessments. Results also underscored the need for routinely conducted analyses of behavioral data.

Keywords: Biomedical interventions; HIV; Risk behavior; Vaccine clinical trials.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Behavioral risk assessment (BRA) in the HVTN.
See this image and copyright information in PMC

References

    1. Ulrich CM, Wallen GR, Feister A, Grady C. Respondent burden in clinical research: when are we asking too much of subjects? IRB. 2005;27(4):17–20. - PubMed
    1. Bradburn N. Respondent burden. Health survey research methods: second biennial conference; Williamsburg, VA. Washington, DC: U.S. Government Printing Office; 1977.
    1. Buchbinder SP, Mehotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al. Efficacy assessment of cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomized, placebo-controlled, test-of-concept trial. Lancet. 2008;372(9653):1881–1893. - PMC - PubMed
    1. Koblin BA, Mayer KH, Noonan E, Wang CY, Marmor M, Sanchez J, et al. Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among Men Who Have Sex with Men participating in a randomized HIV-1 efficacy trial: Step Study. J Acquir Immune Defic Syndr. 2012;60(4):405–413. - PMC - PubMed
    1. Strauss A, Corbin J. Basics of qualitative research: grounded theory procedures and techniques. Newbury Park, CA: Sage; 1990.

Publication types